Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor

Primary hepatic neuroendocrine tumor (PHNET) is rare liver cancer and related prognostic factors are unclear. The aim of this study was to analyze the prognostic risk factors of patients with PHNETs and establish an assessment model for prognosis. The clinical information of 539 patients with PHNETs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jianyang, Li, Xiang, Ding, Xin, Chen, Zhihong, Wu, Yinyan, Zhao, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679223/
https://www.ncbi.nlm.nih.gov/pubmed/36425110
http://dx.doi.org/10.3389/fmed.2022.960235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679223/
https://www.ncbi.nlm.nih.gov/pubmed/36425110
http://dx.doi.org/10.3389/fmed.2022.960235

Ejemplares similares